Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
30.1M
-
Shares change
-
+395K
-
Total reported value, excl. options
-
$527M
-
Value change
-
+$9.42M
-
Put/Call ratio
-
0.76
-
Number of buys
-
68
-
Number of sells
-
-37
-
Price
-
$17.50
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q3 2018
124 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q3 2018.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.1M shares
of 87M outstanding shares and own 34.64% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (3.9M shares), BlackRock Inc. (2.4M shares), FMR LLC (2.29M shares), GREAT POINT PARTNERS LLC (2.12M shares), EAGLE ASSET MANAGEMENT INC (2.07M shares), BVF INC/IL (2.02M shares), VICTORY CAPITAL MANAGEMENT INC (1.54M shares), CARILLON TOWER ADVISERS, INC. (1.5M shares), Vanguard Group Inc (1.46M shares), and STATE STREET CORP (1.17M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.